Furthermore, bile acids (BAs), whose metabolism dysregulation has been linked to steatosis and fibrosis in NAFLD patients, activate YAP via the scaffold protein IQGAP1 [71]. The gene discussed is YAP1; the disease is metabolic dysfunction-associated steatotic liver disease.